Summary
This human intervention study investigated whether dietary supplementation with α-linolenic acid, a plant-derived omega-3 polyunsaturated fatty acid, could modulate inflammatory immune responses in individuals with elevated blood cholesterol. The findings suggest that increased ALA intake may suppress the production of pro-inflammatory cytokines by circulating immune cells, potentially contributing to reduced cardiovascular inflammation risk in this population. The mechanistic link between plant-based omega-3 fatty acids and immune regulation in metabolic disease represents a nutritional pathway of interest for chronic disease prevention.
Regional applicability
Findings are transferable to United Kingdom clinical populations and dietary contexts. ALA is available through common UK foods including flaxseeds, walnuts, rapeseed oil, and leafy greens. The study's focus on hypercholesterolaemic subjects aligns with cardiovascular disease prevention priorities in UK public health policy.
Key measures
Pro-inflammatory cytokine production by peripheral blood mononuclear cells; likely measures of TNF-α, IL-6, IL-1β or similar markers; plasma lipid profiles in hypercholesterolaemic subjects
Outcomes reported
The study examined the effect of dietary α-linolenic acid (ALA) supplementation on production of pro-inflammatory cytokines by peripheral blood mononuclear cells (PBMCs) isolated from hypercholesterolaemic subjects. The primary outcome was inflammatory cytokine production measured in vitro following dietary ALA intervention.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.